Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (F

Konference: 2012 54th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models

Číslo abstraktu: 1641

Autoři: MD Antonio Salar; MD Irit Avivi; MD Jean-Francois Larouche; Doc.MUDr. Andrea Janíková, Ph.D.; Juliana Pereira, PhD; Mike Brewster; Olivier Catalani; Christine McIntyre; Pakeeza Sayyed; Andrew Haynes

Datum přednesení příspěvku: 8. 12. 2012